PT71724A - Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vassodi lator effect and of pharmaceutical compositions containing thern - Google Patents

Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vassodi lator effect and of pharmaceutical compositions containing thern

Info

Publication number
PT71724A
PT71724A PT71724A PT7172480A PT71724A PT 71724 A PT71724 A PT 71724A PT 71724 A PT71724 A PT 71724A PT 7172480 A PT7172480 A PT 7172480A PT 71724 A PT71724 A PT 71724A
Authority
PT
Portugal
Prior art keywords
vassodi
dihidropyridine
thern
lator
hypertensive
Prior art date
Application number
PT71724A
Other languages
English (en)
Other versions
PT71724B (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT71724A publication Critical patent/PT71724A/pt
Publication of PT71724B publication Critical patent/PT71724B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PT71724A 1979-09-01 1980-08-22 Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vasodilator effect and of pharmaceutical compositions containing them PT71724B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2935451A DE2935451A1 (de) 1979-09-01 1979-09-01 Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel

Publications (2)

Publication Number Publication Date
PT71724A true PT71724A (en) 1980-09-01
PT71724B PT71724B (en) 1981-06-17

Family

ID=6079874

Family Applications (1)

Application Number Title Priority Date Filing Date
PT71724A PT71724B (en) 1979-09-01 1980-08-22 Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vasodilator effect and of pharmaceutical compositions containing them

Country Status (25)

Country Link
US (3) US4510310A (pt)
EP (1) EP0026317B1 (pt)
JP (2) JPS5636455A (pt)
AR (1) AR228576A1 (pt)
AT (1) ATE16101T1 (pt)
AU (1) AU545023B2 (pt)
CA (1) CA1142937A (pt)
CS (1) CS228506B2 (pt)
DD (1) DD154014A5 (pt)
DE (2) DE2935451A1 (pt)
DK (2) DK160549C (pt)
EG (1) EG15011A (pt)
ES (1) ES8104228A1 (pt)
FI (1) FI78686C (pt)
GR (1) GR70080B (pt)
HU (1) HU184821B (pt)
IE (1) IE50504B1 (pt)
IL (1) IL60937A (pt)
NO (1) NO159928C (pt)
NZ (1) NZ194805A (pt)
PH (3) PH19749A (pt)
PL (1) PL128310B1 (pt)
PT (1) PT71724B (pt)
SU (1) SU932988A3 (pt)
ZA (1) ZA805372B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts
JPS57200364A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salt
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
GB2111978B (en) * 1981-10-19 1985-05-01 Maruko Pharmaceutical Co 1 4-dihydropyridine compounds
DE3379107D1 (en) * 1982-06-03 1989-03-09 Pierrel Spa Hydroxyimino and alkoxyimino derivatives of 1,4-dihydropyridine, process for the preparation thereof and pharmaceutical composition therefrom
JPS5970667A (ja) * 1982-10-15 1984-04-21 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
JPS59225162A (ja) * 1983-06-03 1984-12-18 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
USRE34618E (en) * 1984-05-22 1994-05-24 Yamanouchi Pharmaceutical Co., Ltd. Injection of nicardinpine hydrochloride and process for the production thereof
DE3423105A1 (de) * 1984-06-22 1986-01-02 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung optisch aktiver 1,4-dihydropyridine
JPS6143165A (ja) * 1984-08-07 1986-03-01 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体の製造法
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
JPS61161263A (ja) * 1985-01-09 1986-07-21 Teijin Ltd １，４−ジヒドロピリジンモノエステルモノカルボン酸の製造法
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
DK142287A (da) * 1986-03-27 1987-09-28 Byk Gulden Lomberg Chem Fab Optisk aktive 1,4-dihydropyridinderivater
US4886819A (en) * 1986-08-27 1989-12-12 The Green Cross Corporation Dihydropyridine derivatives and pharmaceutical composition thereof
JPH0686429B2 (ja) * 1986-08-27 1994-11-02 株式会社ミドリ十字 ジヒドロピリジン誘導体
JPH0755955B2 (ja) * 1986-09-10 1995-06-14 日産化学工業株式会社 光学活性なジヒドロピリジン−５−ホスホン酸エステル
HU196755B (en) * 1986-09-16 1989-01-30 Gyogyszerkutato Intezet Process for production of new substituated amilid derivatives and medical compositions containing them
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
JP2625190B2 (ja) * 1987-03-27 1997-07-02 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング １，４―ジヒドロピリジン―エナンチオマーおよびその製法
EP0287828A1 (de) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Zwischenprodukte und Verfahren
US4889866A (en) * 1987-06-11 1989-12-26 Syntex (U.S.A.) Inc. Arylsulfonyl dihydropyridine derivatives
JPS6429359A (en) * 1987-07-24 1989-01-31 Teijin Ltd 1,4-dihydropyridine derivative and production thereof
DE3821334A1 (de) * 1988-06-24 1989-12-28 Bayer Ag 1,4-dihydropyridin-threonin-derivate, verfahren zu ihrer herstellung, zwischenprodukte und ihre verwendung als arzneimittel
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
DE4011106A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
AT399718B (de) * 1992-04-16 1995-07-25 Lek Tovarna Farmacevtskih Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
ATE146788T1 (de) * 1992-10-30 1997-01-15 Bayer Ag 4-heterocyclophenyl substituierte dihydropyridine
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
ATE234286T1 (de) 1993-12-10 2003-03-15 Bayer Ag Phenyl-substituierte 1,4-dihydropyridine mit cerebraler aktivität
US5478848A (en) * 1994-01-26 1995-12-26 Bayer Corporation Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
DE19532320A1 (de) * 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US20100247646A1 (en) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Extended release tablets of nisoldipine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel

Also Published As

Publication number Publication date
PL226503A1 (pt) 1982-05-24
JPH07600B2 (ja) 1995-01-11
ES494614A0 (es) 1981-04-16
HU184821B (en) 1984-10-29
PH19006A (en) 1985-12-03
AU545023B2 (en) 1985-06-27
NZ194805A (en) 1984-05-31
US4988717A (en) 1991-01-29
DK160549B (da) 1991-03-25
DK164158C (da) 1992-10-12
FI78686C (fi) 1989-09-11
EP0026317B1 (de) 1985-10-16
CS228506B2 (en) 1984-05-14
EG15011A (en) 1985-03-31
GR70080B (pt) 1982-07-27
AU6198280A (en) 1982-03-25
NO159928C (no) 1989-02-22
JPS5636455A (en) 1981-04-09
EP0026317A1 (de) 1981-04-08
ATE16101T1 (de) 1985-11-15
IL60937A0 (en) 1980-10-26
DE2935451A1 (de) 1981-03-19
FI802717A (fi) 1981-03-02
DK164158B (da) 1992-05-18
IE50504B1 (en) 1986-04-30
ES8104228A1 (es) 1981-04-16
PH17914A (en) 1985-01-25
DK368480A (da) 1981-03-02
PH19749A (en) 1986-06-23
DK241390D0 (da) 1990-10-05
DK241390A (da) 1990-10-05
DE3071186D1 (en) 1985-11-21
NO802446L (no) 1981-03-02
AR228576A1 (es) 1983-03-30
IL60937A (en) 1984-02-29
US4849433A (en) 1989-07-18
NO159928B (no) 1988-11-14
PL128310B1 (en) 1984-01-31
CA1142937A (en) 1983-03-15
US4510310A (en) 1985-04-09
JPH05310694A (ja) 1993-11-22
PT71724B (en) 1981-06-17
FI78686B (fi) 1989-05-31
DK160549C (da) 1991-09-16
IE801820L (en) 1981-03-01
SU932988A3 (ru) 1982-05-30
ZA805372B (en) 1981-09-30
DD154014A5 (de) 1982-02-17

Similar Documents

Publication Publication Date Title
PT71724A (en) Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vassodi lator effect and of pharmaceutical compositions containing thern
MY8500062A (en) 1,2,4-troazome deriovatives, process for preparing such compounds and pharmaceutical compositions containing them
IL57020A0 (en) New carbazolyl-(4)-oxypropanolamine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL59914A (en) Esters of acyl-carnitines,process for their preparation and pharmaceutical compositions containing them
PT79783B (en) Process for preparing novel glycerine derivatives and of pharmaceutical compositions containing the same
ZA801680B (en) 2-imidazoline derivatives,process for the preparation thereof and the pharmaceutical composition of the same
ZA777532B (en) 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same
PT69821A (en) Process for the preparation of new 5-phenylpyrazole derivatives the salts thereof and the pharmaceutical compositions containing same
PT76809A (en) Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same
DE3066237D1 (en) 6-substituted-arylpyrido(2,3-d)pyrimidin-7-amines, derivatives and salts thereof, pharmaceutical compositions containing any of the foregoing, and processes for producing any of the foregoing
DE3067564D1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ZA792043B (en) Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
IL60025A (en) Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
DE3061152D1 (en) Pyrazoloindazole derivatives and process for preparing the same and pharmaceutical compositions
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
IL61175A0 (en) 1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them
PT72066A (en) Process for the preparation of novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof
IL47268A (en) Racemic or optically active 4-acyl-1,3,4,5-tetrahydro-2h-1,4-benzo-diazepin-2-ones,process for their preparation and pharmaceutical compositions containing them
PT76557B (en) Process for preparing furan derivatives and addition salts thereof and of pharmaceutical compositions containing the same
DE2964803D1 (en) 2-azaergolines and 2-aza-8(or 9)-ergolenes, process for their preparation and pharmaceutical compositions containing them
DE3066533D1 (en) Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions
PT71211A (en) Process for the preparation of 3-substituted-tetrahydropyrrolo/1,2-a/pyrimidines and pharmaceutical compositions containing the same and new 3-substituted-tetrahydro-pyrrolo/1,2-a/ pyrimidines
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances
PT77730B (en) Process for preparing acridanone derivatives and of pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19981231